Best Gastroenterology Journals (2026): Ranked by Impact and Accessibility

The highest-impact GI journal publishes clinical evidence that changes how gastroenterologists and hepatologists practice globally. If you have a large, well-designed trial with definitive results in GI or liver disease, this is where it belongs. The journal benefits from The Lancet brand and editorial infrastructure, with a strong emphasis on global health relevance. It doesn't publish much basic or translational science, so save your bench work for Gut or Gastroenterology.

The AGA's flagship journal is the top destination for clinical GI research in the US. Gastroenterology publishes clinical trials, large cohort studies, systematic reviews, and translational research across all GI subspecialties. The journal leans slightly more clinical than Gut, meaning it's more receptive to large observational studies with strong statistical evidence, even when the mechanism isn't fully characterized. Gastroenterology also publishes AGA technical reviews and clinical guidelines, giving published papers direct influence on practice standards.

Gut (published by BMJ) is the top venue for translational GI research. The journal demands mechanistic depth alongside clinical relevance. If you have a well-designed clinical study, Gut's editors will ask: what's the biology behind the result? That translational requirement makes Gut harder to publish in for purely clinical work but more rewarding for research that bridges bench and bedside. The editorial perspective is European, though excellent work from anywhere gets published.

EASL's flagship covers all aspects of liver disease with a European editorial perspective. If your paper is hepatology-focused, JoH often provides a better fit than competing for space against all GI subspecialties at Gut or Gastroenterology. The journal publishes EASL clinical practice guidelines, which carry substantial authority in European hepatology practice.

The AASLD journal is JoH's American counterpart. Hepatology publishes basic, translational, and clinical liver research with North American emphasis. For US-based hepatology researchers, Hepatology often makes more strategic sense than JoH because the AASLD readership is your primary professional community.

AJG is the ACG's journal, focused on clinical gastroenterology with a practitioner-oriented perspective. It's more accessible than Gut or Gastroenterology and publishes more endoscopy research, motility studies, and clinical practice papers. If your paper answers a clinical question GI practitioners face daily, AJG reaches exactly the right audience.

CGH is the AGA's practice-oriented journal, complementing Gastroenterology's research focus. It publishes clinical reviews, systematic reviews, and shorter clinical research reports. If your paper is clinically valuable but not quite competitive for Gastroenterology, CGH is the natural cascade within the AGA family.

AP&T fills a niche for GI pharmacology and therapeutic studies. Drug trials, pharmacokinetic studies, and therapeutic management research across all GI subspecialties find a focused audience here. The acceptance rate (~20%) is more realistic than the elite journals.

The ASGE journal is the top venue specifically for endoscopy research. Procedural outcomes, new endoscopic techniques, and device studies belong here rather than competing at Gut or Gastroenterology where endoscopy competes against all other GI subspecialties.

For microbiome-GI interaction research specifically, Gut Microbes provides a focused audience. The journal publishes mechanistic microbiome studies, host-microbe interaction research, and translational microbiome science. If Gut rejected your microbiome paper for insufficient functional validation, Gut Microbes may be more receptive.

JGH is the leading Asia-Pacific GI journal, publishing clinical and translational research with particular strength in Asian GI conditions (hepatitis B, gastric cancer, H. pylori). For research primarily relevant to Asian populations, JGH reaches the right clinical audience.

For sound GI research that doesn't clear the competitive bars at higher-tier journals, BMJ Open Gastroenterology provides open-access publication with a reasonable APC. The acceptance rate (~45%) makes it accessible for well-conducted studies.

If your paper is a large clinical trial with definitive results: Start with Lancet Gastroenterology and Hepatology, then Gastroenterology, then Gut.

If your paper is translational GI research with mechanistic data: Start with Gut, then Gastroenterology.

If your paper is hepatology-focused: Journal of Hepatology (European cohort) or Hepatology (American cohort) first, bypassing the GI generalist journals.

If your paper is clinical GI practice-focused: AJG or CGH, which reach practicing gastroenterologists directly.

If your paper involves endoscopy: Gastrointestinal Endoscopy first, then Gut or Gastroenterology only if the findings have broad GI implications.

If your paper is microbiome research: Gut (if mechanistic and translational), Gut Microbes (if focused on microbiome interactions specifically).